GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » Equity-to-Asset

Heart Test Laboratories (Heart Test Laboratories) Equity-to-Asset : 0.80 (As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Heart Test Laboratories's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $8.63 Mil. Heart Test Laboratories's Total Assets for the quarter that ended in Jan. 2024 was $10.80 Mil. Therefore, Heart Test Laboratories's Equity to Asset Ratio for the quarter that ended in Jan. 2024 was 0.80.

The historical rank and industry rank for Heart Test Laboratories's Equity-to-Asset or its related term are showing as below:

HSCS' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.9   Med: -0.07   Max: 0.8
Current: 0.8

During the past 4 years, the highest Equity to Asset Ratio of Heart Test Laboratories was 0.80. The lowest was -2.90. And the median was -0.07.

HSCS's Equity-to-Asset is ranked better than
74.94% of 866 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs HSCS: 0.80

Heart Test Laboratories Equity-to-Asset Historical Data

The historical data trend for Heart Test Laboratories's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories Equity-to-Asset Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
Equity-to-Asset
0.16 -0.99 -2.90 0.07

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 0.07 -0.20 -0.70 0.80

Competitive Comparison of Heart Test Laboratories's Equity-to-Asset

For the Medical Devices subindustry, Heart Test Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heart Test Laboratories's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Heart Test Laboratories's Equity-to-Asset falls into.



Heart Test Laboratories Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Heart Test Laboratories's Equity to Asset Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Equity to Asset (A: Apr. 2023 )=Total Stockholders Equity/Total Assets
=0.231/3.287
=0.07

Heart Test Laboratories's Equity to Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

Equity to Asset (Q: Jan. 2024 )=Total Stockholders Equity/Total Assets
=8.634/10.801
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heart Test Laboratories  (NAS:HSCS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Heart Test Laboratories Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092

Heart Test Laboratories (Heart Test Laboratories) Headlines

From GuruFocus

HeartSciences Announces Further Internationalization of its Patent Portfolio

By Stock market mentor Stock market mentor 02-03-2023

HeartSciences to Present at the Planet MicroCap Showcase: VEGAS 2023

By sperokesalga sperokesalga 04-17-2023